rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1998-3-24
|
pubmed:abstractText |
Enterococcus faecium has received increased attention, primarily due to the emergence of vancomycin resistance. The purpose of this investigation was to study the epidemiological characteristics of vancomycin-resistant E faecium (VRE) bacteremia and to determine the clinical impact of vancomycin resistance on the outcome of patients with this infection.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0003-9926
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
9
|
pubmed:volume |
158
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
522-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9508230-Anti-Bacterial Agents,
pubmed-meshheading:9508230-Bacteremia,
pubmed-meshheading:9508230-Drug Resistance, Microbial,
pubmed-meshheading:9508230-Enterococcus faecium,
pubmed-meshheading:9508230-Female,
pubmed-meshheading:9508230-Gram-Positive Bacterial Infections,
pubmed-meshheading:9508230-Humans,
pubmed-meshheading:9508230-Male,
pubmed-meshheading:9508230-Middle Aged,
pubmed-meshheading:9508230-Retrospective Studies,
pubmed-meshheading:9508230-Treatment Outcome,
pubmed-meshheading:9508230-Vancomycin
|
pubmed:year |
1998
|
pubmed:articleTitle |
Enterococcus faecium bacteremia: does vancomycin resistance make a difference?
|
pubmed:affiliation |
Department of Medicine, Northwestern University Medical School, Chicago, Ill 60611, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|